Oncology & Cancer
Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma
Researchers at Children's Hospital of Philadelphia (CHOP) announced a significant breakthrough in understanding chemotherapy resistance in high-risk neuroblastoma, a common and potentially deadly childhood cancer arising ...
Aug 14, 2024
0
0